Dr Dominic Heaney MA MRCP PhD
Curriculum Vitae
Dr Dominic Heaney MA (Cantab) MB BCh (Oxon)
Consultant Neurologist and Honorary Senior Lecturer National Hospital for Neurology and Neurosurgery Dr Dominic Heaney MA MRCP PhD
Contact Details

Sharon VigliancoPrincess Grace Hospital30-32 Devonshire StreetLondon W1G 6PU Education and Qualifications
JCHMT Certificate of Completion of Specialist Training, Neurology Current Position and Areas of Expertise
Consultant Neurologist and Honorary Senior Lecturer at National Hospital for Neurology and Neurosurgery and UCLH NHS Hospitals NHS Trust, and the Institute of Neurology, UCL.
Medico-legal expertise
Since 2004, I have established a medico-legal practice, and work within a department that has considerable experience in this area. I am able to offer expert specialist opinions on manyareas of neurological practice – including the neurological consequences of trauma (such as headache, post-concussion syndrome, headache and exacerbation of existing conditions such as multiple sclerosis). Clients are assessed in the private consulting rooms at Queen Square, 63 Great Ormond Street, London WC1N 3BG or at 30 Devonshire Street, London W1G 6PU.
Clinical and academic expertise
My medico-legal work is supported and informed by my clinical and academic practice as a consultant neurologist at UCLH NHS Trust, which is a large London teaching hospital, and The National Hospital for Neurology and Neurosurgery, Queen Square. General neurology
I manage and deliver a service that is actively involved in a wide-range of neurological problems, including headache, brain injury, multiple sclerosis, peripheral nerve and muscle disorders, and stroke. I am one of 6 neurologists providing a liaison service to a range of departments in UCLH, including A&E, medicine, oncology and the surgical specialities. Dr Dominic Heaney MA MRCP PhD

I maintain a specialist interest in epilepsy, and I work as an honorary
senior lecturer with the Department of Clinical and Experimental Epilepsy,
who have an international reputation in terms of management of complex
epilepsy – including neuro-surgical treatment. In liaison with A&E and
acute services I have established and direct a first seizure/syncope
diagnostic clinic
, which establishes precise diagnosis, treatment and
prognosis for individuals who have suffered episodes of loss of
consciousness – including those occurring in relation to traumatic head
Obstetric neurology Together with a consultant obstetrician and consultant obstetric physician,
I co-direct the UK’s only obstetric-neurology clinic. This clinic
specialises in the pre-conception counselling, pregnancy, and immediate
post-natal care of women who become pregnant with – or who develop –
neurological problems in relation to pregnancy. Through this clinic I have
also developed expertise in the area of teratogenesis in relation to drugs
used to treat neurological conditions in pregnancy.
Through my PhD research, I have an academic background in economic
outcomes research, and continue to publish on issues concerning the
social, employment and economic outcomes of neurological illness.
Clinical Governance Through my NHS Practice, I am actively involved in clinical governance,
but have particular expertise through my role as Deputy Caldicott Guardian and also NHNN representative on the UCLH Use of Medicines Committee.
The following colleagues have acted as referees in the past, and I would be able to arrange for them to provide further recommendation, should this be required: Professor John Duncan PhD FCRP. Professor of Neurology: Box 29, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; [email protected] Professor Josemir Sander MD PhD. Professor of Neurology: Box 29, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; [email protected] Dr Alan Thompson PhD FRCP. Professor of Neurology: National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; [email protected] Dr Dominic Heaney MA MRCP PhD
Research and publications (since 2001, not including
abstracts or platform presentations)

PhD thesis (University of London, 2002): “Anti-epileptic drugs: economic considerations
in clinical practice”

The economic impact of anti-epileptic drugs was investigated using modelling techniques and also methods that incorporated patient preferences. Research was based on a large number of patient interviews performed within a clinical setting. Socio-economic factors were considered. Cost-effectiveness and cost-benefit analyses were performed. Overall, my research demonstrated that economic evaluation is most meaningful in clinical practice when it incorporates patient opinion.
Heaney DC, Bell GS, Sander JW. The socioeconomic, cultural, and emotional implications of starting
or withholding treatment in a patient with a first seizure. Epilepsia. 2008; 49 Suppl 1:35-9
Heaney DC, Sander JW. “The unknown cost of epilepsy misdiagnosis in England and Wales”.
Seizure. 2007 Jun;16(4):377
Heaney D, Sander JW. “Antiepileptic drugs: generic versus branded treatments”. Lancet Neurology
2007 May;6(5):465-8.
Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart J, Thompson A. “Home versus outpatient
administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial”.
Lancet Neurology. 2006 Jul;5(7):565-71
Heaney D, Sander JWAS. Cost-effectiveness of Carbamazepine. Expert Review of Pharmaco-
economics and Outcomes Research
2006 Vol. 6 No. 1 Pages 13-18
Farrell R, Heaney D, Giovannoni G. Emerging disease modifying therapies for multiple sclerosis.
Expert Opinion Emerging Drugs 2005, Vol. 10, No. 4, Pages 797-816
Heaney D, Swash M, Geddes M et al. Sarcoid polyneuropathy responsive to intravenous
immunoglobulin. Muscle Nerve 2004; 29(3): 447-50
Heaney D et al. Socioeconomic variation in incidence of epilepsy: prospective community based
study in south east England. BMJ 2002; 325:1013-6.
Heaney D, Sander JW. Reduzindo a carga economica da epilepsia. ComCiencia 2002; 34;75-79
Begley C et al. ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: Final report 1998-2001. Epilepsia 2002;43(6):668-73 MacDonald BK, Mummery CJ, Heaney D. Health needs of asylum seekers and refugees. Head injury
needs to be taken into consideration in survivors of torture. BMJ 2001; 323:230
Heaney D, Sander JW, Shorvon SD et al. Comparing the cost of epilepsy in eight European
countries. Epilepsy Res. 2001;43(2):88-95
Reviews (*indicates peer reviewed)
Heaney D & Begley C. Economic evaluation of epilepsy treatment: a review of the literature.
Epilepsia 2002;43 ILAE Suppl 4:10-6*
Dr Dominic Heaney MA MRCP PhD
Heaney D & Beran R. Economics in epilepsy treatment choices: our certain fate?
Epilepsia 2002;43 ILAE Suppl 4:32-8*
Book Chapters and Reports
Heaney D, Shorvon SD. Epilepsy – Epidemiology, definitions and diagnostic procedures. In: Women
with epilepsy – a handbook of health and treatment issues. Ed Morrell,M. 1st edition 2003
Heaney D, Sander JW. Cost benefit analysis in epilepsy. In: Epilepsy in Latin America. Ed. Devilat M,
Campos M, Marinis A. 1st edition. Catholic University of Chile Press 2000
Shorvon SD, Thompson P, Heaney D. Epilepsy. In: Neurological Rehabilitation. Ed. Greenwood RJ,
Barnes M, McMillan T, Ward D. 2nd edition. Churchill Livingstone Press 2000
Heaney D, Shorvon SD. Topiramate. In: A Handbook of Clinical Pharmacology. Ed. Eadie MJ. 2nd


substituted by petitioner Philman Marine Agency, Inc. (Philman), Carlos Salinas and petitioner DOHLE (IOM) Limited (DOHLE). The Factual Antecedents On September 15, 2002, Armando entered into a nine-month contract of employment7 with DOHLE, through its local agent PTCI. He was assigned to work as a 2nd mate on board the vessel “INGA-S.” His basic monthly salary was US$966.00 on

Microsoft word - science

1. The 2-oxoacid dehydrogenase complex of haloferax volcanil ; Dina Musaed Al-Mailem; 2006. QR 97 .S3 M34 2006 SC 2. Ab Initio study of the absorption of organic molecules on metal oxide surfaces ; Mariam Riad Abdallah; Kuwait University: Kuwait, 2007. QD 505 .A23 2007 SC 3. Alkalinity and salinity loving (tolerant) oil-utilizing microorganisms from Kuwait coasts ; Rasha Ham

Copyright © 2009-2018 Drugs Today